Dompe Holdings
Via Santa Lucia, 6, Milano, Lombardia, 20122, Italy
Overview
DOMPE is a biopharmaceutical company that is committed to research and development to meet unsatisfied therapeutic needs. The company's products are engaged in the development and distribution of ethical drugs and self-medication, adjuvants, medical devices and cosmetics, and in the fields of vitamin and mineral supplements and personal hygiene. The therapeutic areas include cardiovascular, gastrointestinal, pediatrics, neurology, urology, ophthalmic, stomatology, and respiratory. Founded in 1940, Dompe is headquartered in Milan, Italy.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 5
Sector focus
- Biotechnology
- Health Care
Investment portfolio
- mPharma
Participated · Equity · May 2020
Founded in 2013, mPharma operates the Mutti pharmacy network, an asset-light franchise model that lets independent pharmacies join its platform while retaining ownership. The company uses proprietary software to optimize inventory management, pricing, and supply-chain logistics, reducing costs and improving medicine availability for consumers. Its QualityRx program standardizes pharmacy operations and quality of care. mPharma’s network spans multiple African countries, and it is now prioritizing expansion into Francophone West Africa. More than half of its newest capital injection will fund launches in Togo and Benin while enhancing inventory efficiency across its multi-pharmacy footprint. By integrating technology with on-the-ground pharmacy partnerships, mPharma aims to build resilient local health systems and broaden equitable access to essential medicines.